Literature DB >> 1693764

Time course of the alteration in dorsal horn substance P levels following formalin: blockade by naloxone.

Kenneth E McCarson1, Barry D Goldstein.   

Abstract

Substance P (SP) found in the dorsal horn of the spinal cord has been proposed as a mediator of nociception. Formalin injected into the hind paw of a rat as a nociceptive stimulus has been shown to increase the amount of immunoreactive SP in the dorsal horn, perhaps by decreasing SP release from primary afferent neurons. These SP changes may be due to the actions of endogenous opiates which can block SP release from primary afferent neurons. In order to determine the time course of SP changes in the dorsal horn and their modulation by naloxone, anesthetized rats pretreated subcutaneously with naloxone or saline were injected in the right hind paw with 0.4 ml of either saline or 5% formalin. After various time intervals, the animals were perfused and the lumbar enlargement of the spinal cord removed. Immunohistochemical staining and manual photometry were used to quantitate SP-like immunoreactivity (SPLI) in the dorsal horn. The results show that saline injection produced an increase in SPLI lasting 20 min, while formalin produced a biphasic effect with early (0-20 min) and late (20-60 min) increases in SPLI. Naloxone pretreatment 30 min prior to hind paw injection partially blocked the initial SPLI increase due to saline or formalin. However, this was not the case if naloxone was injected 2 min following hind paw injection. The formalin-induced late SPLI increase was blocked by naloxone only if it was administered prior to the formalin. This blockade of SPLI increases in the dorsal horn by naloxone implies that endogenous opioid systems play a role in the control of SP levels in the dorsal horn during nociception.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693764     DOI: 10.1016/0304-3959(90)91113-W

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  5 in total

1.  Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain.

Authors:  Andrew H Ahn; Allan I Basbaum
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

2.  Intrathecal administration of doxepin attenuated development of formalin-induced pain in rats.

Authors:  J Wordliczek; M Banach; D Labuz; B Przewlocka
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

3.  Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.

Authors:  N M Rupniak; S Boyce; A R Williams; G Cook; J Longmore; G R Seabrook; M Caeser; S D Iversen; R G Hill
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

4.  Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.

Authors:  N M Rupniak; J K Webb; A R Williams; E Carlson; S Boyce; R G Hill
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain.

Authors:  Yi-Ruu Lin; Hwei-Hsien Chen; Yu-Chin Lin; Chien-Hsin Ko; Ming-Huan Chan
Journal:  J Biomed Sci       Date:  2009-10-16       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.